Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Avidia Inc.

Division of Amgen Inc.
www.avidia.com

Latest From Avidia Inc.

Financings Of The Fortnight: Corporate Venture Contributing In A Big Way

Once an unlikely scenario, corporate venture funds now are making up a larger and larger part of investment rounds for early-stage biotechs; these investments are buoyed by VCs launching their own firms. Plus news on recent financing activity from Avaxia Biologics, Clovis Oncology, Protagonist Therapeutics and Dermira.

BioPharmaceutical North America

AbbVie Joins Avaxia Board, Becomes An Early Investor In The Gut Therapy Biotech

AbbVie has been filling out its pipeline with small deals that could result in a follow-on drug to its blockbuster Humira; it’s most recent investment is in a small company doing further work in the space.

BioPharmaceutical North America

Alvine Hopes To Bring The First Celiac Drug To Market With New Partner AbbVie

Alvine and AbbVie have inked a deal that could allow the larger company to acquire the biotech based on results of a Phase IIb trial for its celiac disease treatment.

BioPharmaceutical Strategy

Biologics Swing For The Fences: Payer Perspectives On Antibodies In Primary Care

Companies with large-molecule expertise increasingly are eyeing primary care markets, confident that improvements in safety and efficacy will make them competitive with oral standards of care.

BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Inflammation
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Amgen Inc.
  • Senior Management
  • Peter Van Vlasellaer, PhD, CEO
    Jose-Carlos Gutierrez-Ramos, PhD, SVP, Research & Non-Clinical Dev. & CSO
  • Contact Info
  • Avidia Inc.
    Phone: (650) 404-2000
    2450 Bayshore Pkwy.
    2nd Fl.
    Mountain View, CA 94043
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register